RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DELFANTI S
Collezione AOU Alessandria

Items : 9

Quality of life in patients with PICC diagnosed with mesothelioma: Results of a multicenter epidemiological survey (LifePICC). in The journal of vascular access / J Vasc Access. 2025 Jan;26(1):217-227. doi: 10.1177/11297298231202046. Epub 2023 Oct 24.

2025
ASL Cuneo 2
AOU Alessandria
ASL Alessandria

Gnani C; Riili G; Maconi A; Delfanti S; Ferrero E; De Angelis A; Riccio C; Gatti D; Cassinari A; Di Matteo R; Crivellari S; Bolgeo T;

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report. in Frontiers in oncology / Front Oncol. 2024 Apr 15;14:1378530. doi: 10.3389/fonc.2024.1378530. eCollection 2024.

2024
AOU Alessandria

Faccioli E; Grosso F; Dell'Amore A; Delfanti S; Zambello G; Cerbone L; Canu G; De Angelis A; Sambataro V; Pezzuto F; Barbieri P; Pasello G; Calabrese F; Rea F;

Unprecedented long-term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo- and immunotherapeutic regimens. in Thoracic cancer / Thorac Cancer. 2023 Feb;14(5):524-527. doi: 10.1111/1759-7714.14789. Epub 2023 Jan 4.

2023
AOU Alessandria
AOU San Luigi di Orbassano

Bertino P; Righi L; Cimorelli A; Bertolotti M; Boccuzzi F; Crivellari S; Delfanti S; De Angelis AM; Cerbone L; Grosso F;

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. in Lancet (London, England) / Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3.

2023
AOU Alessandria

Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; et alii...

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin. in Clinical colorectal cancer / Clin Colorectal Cancer. 2023 Dec;22(4):450-456.e1. doi: 10.1016/j.clcc.2023.08.005. Epub 2023 Aug 11

2023
AOU Alessandria

Ghelardi F; Raimondi A; Morano F; Randon G; Pannone A; Guaglio M; Mazzoli G; Nasca V; Milione M; Leoncini G; Sabella G; Greco GF; Lampis BR; Galassi M; Delfanti S; Nannini M; Intini R; Baratti D; Di Bartolomeo M; Deraco M; Pietrantonio F;

Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study. in International journal of molecular sciences / Int J Mol Sci. 2022 May 21;23(10):5786. doi: 10.3390/ijms23105786.

2022
AOU Alessandria
ASL Alessandria

Ceresoli GL; Marchini S; Allavena P; Zucali PA; Muzio A; Delfanti S; De Angelis A; Libener R; Penpa S; Callari M; Inglesi A; Amodeo R; Lupi M; Bosetti C; Vedovelli L; De Simone I; Moracci L; Olteanu GE; Pezzuto F; Paracchini L; Mannarino L; Calabrese F; D'Incalci M; Grosso F;

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23.

2022
AOU Alessandria
AOU Novara

Parisi A; Delfanti S; Santoro A; Mazzoni F; Filetti M; Berardi R; Martinez-Vila C; Fusco V; Shawe-Taylor M; Patriarca A; Bruna R; Ruiz-Camps I; Gaidano G; Zoratto F; Roldán E; Fox L; Doonga K; Fort-Culillas R; Saoudi-Gonzalez N; Perachino M; Bain HD; Yu T; Cruz CA; Rizzo G; Eremiev S; Sharkey R; Carmona-García MC; Rossi S; Liñan R; et alii...

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 Oct 29;11(11):2015. doi: 10.3390/diagnostics11112015.

2021
AOU Alessandria

Grosso F; Mannucci M; Ugo F; Ferro P; Cassinari M; Vigani A; De Angelis AM; Delfanti S; Lia M; Guaschino R; Barbero S; Roncella S; Giannoni U; Bertolotti M; Pistillo MP; Fontana V;